CLINICAL_TRIALS
trial_result
· 2020-01-13
Clinical Trial Update: TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma [NA]
Summary
Clinical trial update for TCR-α/β and CD19 depleted stem cell grafts from haplo donors in relapsed lymphoma; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Lymphoma | NA | Status: COMPLETED | Results posted: 2020-01-13